Human Gene Mutation Database (HGMD) Professional
Expert-curated content to streamline variant classification for hereditary workflows
Analyze with Precision. Interpret with Confidence.
HUMAN EXPERTISE vs. ARTIFICIAL INTELLIGENCE
Can AI replace human curation of genetic variants?
Together with deep learning (DL) and machine learning (ML), AI is currently a buzzword across almost all scientific disciplines and has the potential to revolutionize diagnostic approaches in inherited diseases. But when it comes to variant curation, is AI capable of replacing human expertise? In a new study, Stanford University compares data quality from their Automatic VAriant evidence DAtabase (AVADA) to the Human Gene Mutation Database (HGMD).
Trust HGMD Professional for the answers you need
When a family has a child with a rare undiagnosed condition or a couple is planning their next chapter, they want assurance that their doctors are considering every peer-reviewed paper and all available evidence in their quest for an answer.
HGMD Professional remains the largest, manually curated resource for finding disease-causing mutations. Founded and maintained by the Institute of Medical Genetics at Cardiff University, the database attempts to collate all known (published) gene lesions responsible for human inherited disease, giving you the best possible chance of reaching a diagnosis.
On-demand webinar
Can you trust AI for germline variant curation?
When it comes to variant curation, is AI capable of replacing human expertise? Join us for a live webinar where we explore why manual curation is irreplaceable in clinical genomics.
Discover more disease-causing mutations
456,702
detailed mutation reports
All data is based on published, peer-reviewed literature that has been manually curated and evaluated for accuracy.
45,000+
new mutation reports per year
Every quarter, HGMD Professional content and functionality is updated to ensure you remain informed on the latest findings.
11,500+
detailed summary reports
For certain mutations, HGMD Professional includes summaries of disease-associated/functional polymorphisms.
What's new in the latest HGMD Professional release?
The fall release is now available, adding 12,617 new entries to the world’s largest collection of human inherited disease mutations. In total, HGMD Pro 2023.3 now contains 456,702 expert-curated mutations.
View the complete HGMD Professional statistics
Did you know the public version of HGMD is 3 years behind HGMD Professional? Explore our resources to view the complete database statistics, rate of publication, and access papers and tutorials.
“QIAGEN’s HGMD provides us with access to curated, peer-reviewed evidence that will support more precise, comprehensive variant interpretation. Pairing that with QIAGEN’s automated and scalable informatics framework facilitates our day-to-day secondary and tertiary bioinformatics analyses, and will help improve the quality of care for patients.”
Stan Letovsky, PhD
Vice President of Data Sciences and Bioinformatics at LabCorp
Expert-curated content updated quarterly to keep you current
HGMD is powered by a team of expert curators at Cardiff University. Data are collected weekly by a combination of manual and computerized search procedures. In excess of 250 journals are scanned for articles describing germline mutations causing human genetic disease. The required data are extracted from the original articles and augmented with the necessary supporting data.
The number of disease-associated germline mutations published per year has more than doubled in the past decade (Figure 1). As rare and novel genetic mutations continue to be uncovered, having access to the latest scientific evidence is critical for timely interpretations of next-generation sequencing (NGS) data.
Figure 1. Mutation entries in HGMD Professional. The number of inherited disease-associated germline mutations published per year has more than tripled (3x) since 2010.
White paper
Avoid the knowledge blind spot
Elisha Cooke-Moore, a wife and working mother of five in southern Oregon, underwent a series of unnecessary surgeries, including a double mastectomy and hysterectomy. These surgeries were based on misinterpreted genetic test results, which led her to believe that she had pathogenic MLH1 and BRCA1 mutations.
These false positives and the corresponding inappropriate course of treatment pursued caused her to experience early menopause, multiple follow-up surgeries, and post-traumatic stress disorder.
The outcome could have been different if Elisha’s genetic test results had been correctly interpreted.
Discover just how easy it is to incorporate HGMD into your existing variant annotation pipeline.
Technical note
Using HGMD mutation data with popular variant annotation tools
Numerous free or open source variant annotation tools are available today to extract, annotate and analyze the genomes and their identified variants coming from NGS methods.
However, the value derived from variant annotation is directly related to the information resource selected for annotation. In this technical note, we provide a guide for using HGMD data with three tools: ANNOVAR, snpEff, and VariantAnnotation (Bioconductor).
Why you should upgrade to HGMD Professional
If you currently use the public version of HGMD, there is a lot of content that you are missing. Not only is the public version of the database three years behind in terms of published mutation entries, it lacks a multitude of search features critical to elucidating clinically significant associations.
For example, only in HGMD Professional can you search for a mutation by chromosome location, gene ontology or phenotype. But that’s not all. See the full comparison between the public and professional versions of HGMD below.
Expanding into clinical test reporting?
For clinical labs looking to expand into hereditary disease testing, QIAGEN Clinical Insight (QCI) Interpret reproducibly translates highly complex NGS data into standardized reports using current clinical evidence from the QIAGEN Knowledge Base, which consists of over 40 public and proprietary databases, including HGMD Professional.
QCI Interpret for Hereditary Diseases delivers manually curated evidence directly to your pipeline. You receive links to all articles, auto-computed ACMG/AMP classifications, and access to over 1 million unpublished variant-phenotype relationships from the QIAGEN Knowledge Base.
QCI Hereditary Disease applications:
- Hereditary cancer
- Expanded Carrier Screening
- Rare and undiagnosed diseases
- Whole exome sequencing (WES)
- Whole genome sequencing (WGS)
Resources
Learn more about HGMD Professional
Brochure
Human Gene Mutation Database (HGMD) Professional
Download this brochure to learn more about HGMD Professional, with detailed information on use-cases, applications, and customer testimonials.
Case study
Rockefeller University Builds Mutation Analysis Tools with HGMD
Find out how scientists at Rockefeller University are using HGMD to rapidly sort through exome data and find disease-causing mutations.
Video tutorials
How to search by gene, mutation, and phenotype in HGMD Professional
Through step-by-step tutorials, we show you how to use a multitude of search functions only available in HGMD Professional.
Request a free trial
of HGMD
Discover the difference of HGMD Professional with a free, no-obligation trial of the industry-leading database.
Related clinical testing solutions
QCI Interpret
Expand your clinical interpretation with expert-curated software for variant classification of any assay, covering any indication, on your sequencing platform
QCI Precision Insights
Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel
Clinical Analysis and Interpretation Services
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities